Kymera Therapeutics KYMR
NASDAQ KYMR
$110.12 -1.67 (-1.49%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) EV to FCF (2020 - 2021)

Updated

Kymera Therapeutics' (KYMR) EV to FCF was 34.30 for Q2 2021, up 69.0% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) EV to FCF (2020 - 2021) Analysis & Trends

Over the twelve months ended Jun 30, 2021, Kymera Therapeutics' EV to FCF came in at 17.07; for FY2020, it was 9.86.

  • Per Business Quant data, the three quarters before Q2 2021 came in at 20.29 (Q1 2021), 9.86 (Q4 2020) and 4.18 (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kymera Therapeutics 9.25 Bn 6.56 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 34.30
Mar 31, 2021 20.29
Dec 31, 2020 9.86
Sep 30, 2020 4.18
API Access

Kymera Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=KYMR&period=max&api_key=YOUR_API_KEY